BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+9.77%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$713M
AUM Growth
+$713M
(-19%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-30.64%
Top 10 Holdings %
Top 10 Hldgs %
55.41%
Holding
67
New
4
Increased
8
Reduced
17
Closed
16
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$15.7M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$6.58M |
| 3 |
DexCom
DXCM
|
$4.18M |
| 4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$3.9M |
| 5 |
CORI
Corium International, Inc.
CORI
|
$3.63M |
Top Sells
| 1 |
PGNX
Progenics Pharmaceuticals Inc
PGNX
|
$65.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$23.5M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$21.7M |
| 4 |
GNMX
Aevi Genomic Medicine, Inc.
GNMX
|
$17.5M |
| 5 |
ATRS
Antares Pharma, Inc.
ATRS
|
$15.1M |
Sector Composition
| 1 | Healthcare | 89.39% |
| 2 | Financials | 0% |
